Dilute Sodium Hyaluronate (Healon) in the Treatment of Ocular Surface Disorders

Overview

Journal Ann Ophthalmol

Specialty Ophthalmology

Date 1985 Mar 1

PMID 3873200

Citations 19

Authors

J C Stuart

J G Linn

Affiliations

Soon will be listed here.

Abstract

The use of dilute (1/10%) sodium hyaluronate (Healon) eyedrops has given definite subjective patient improvement in a variety of ocular surface disorders, especially keratitis sicca. No adverse effects of the sodium hyaluronate drops have been encountered in patients who have used the drops for as long as two years. Masked trials and objective improvement of corneal staining patterns have also confirmed its efficacy.

Citing Articles

Real-World Treatment Outcomes of an Artificial Tear Containing Arabinogalactan, Hyaluronic Acid and Trehalose Among Subjects with Dry Eye.

Bedei A, Rocha Cabrera P, Oliveira L, Castellini L, De Grazia G, Remiddi S Clin Ophthalmol. 2025; 19():83-91.

PMID: 39801568 PMC: 11724676. DOI: 10.2147/OPTH.S480668.

Evaluation of Dry Eye Treatment with Sodium Hyaluronate- and Dexpanthenol-Containing Eye Drops on Ocular Surface Improvement after Cataract Surgery.

Koppe M, Hallak M, Stengele A, Khoramnia R, Auffarth G Diagnostics (Basel). 2024; 14(11).

PMID: 38893624 PMC: 11171816. DOI: 10.3390/diagnostics14111097.

Synergistic Properties of Arabinogalactan (AG) and Hyaluronic Acid (HA) Sodium Salt Mixtures.

Di Mola A, Summa F, Oliva P, Lelj F, Remiddi S, Silvani L Molecules. 2021; 26(23).

PMID: 34885828 PMC: 8658974. DOI: 10.3390/molecules26237246.

Why Chain Length of Hyaluronan in Eye Drops Matters.

Muller-Lierheim W Diagnostics (Basel). 2020; 10(8).

PMID: 32717869 PMC: 7459843. DOI: 10.3390/diagnostics10080511.

Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water.

Tredici C, Fasciani R, Villano A, Gambini G, Caporossi A Eur J Ophthalmol. 2020; 30(3):430-438.

PMID: 32064920 PMC: 7221862. DOI: 10.1177/1120672120907311.